Eppinix XL (ropinirole) has been launched for the treatment of Parkinson’s disease as initial monotherapy or in combination with levodopa over the course of the disease. The range includes 3mg and 6mg prolonged-release tablets in addition to the 2mg, 4mg and 8mg strengths of ropinirole already available.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Handy calculators and conversions for primary care.